跳至主要内容
临床试验/NCT05003011
NCT05003011Unknown不适用

Correlation of Hemodynamics Via Pulmonary Artery Catherization and the Cardiospire

Respirix, Inc.1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2021年9月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
160
试验地点
1
主要终点
Correlation and Validation of data

研究概览

简要总结

This study is designed as an observational study to collect Cardiospire cardiogenic oscillation signal (COS) and CO output parameters from the Pulmonary Artery Catheter in intubated patients.

详细描述

Respirix has developed a non-invasive hemodynamic monitoring device called the Cardiospire. The Cardiospire detects minor, cyclic waveforms caused by Cardiogenic Oscillations (COS) and uses features of the COS waveform to provide information about hemodynamics.

This study is designed as an observational study to collect paired readings of the Cardiospire cardiogenic oscillation signal (COS) and the ground truth CO output parameters, including Pulmonary Artery Pressure diastolic (PAPd), systolic (PAPs), Stroke Volume (SV), and Cardiac Output (CO) from the Pulmonary Artery Catheter in intubated patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years of age
  • Intubated
  • Pulmonary artery catheter
  • Patient or patient's legally authorized representative is able to provide informed consent

排除标准

  • Subjects who, at the principal investigator's determination, would not be appropriate for this study

结局指标

主要结局

Correlation and Validation of data

时间窗: 1.5 years

Collected Cardiospire data from next 150 patients will be analyzed in comparison to PAC data for correlation and validation purposes.

Repeatable Data Verification

时间窗: 3 months

First 10 patient Cardiospire data will be processed and analyzed to determine if deemed repeatable for cardiogenic oscillations (COS).

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验